Subungual melanoma: a diagnostic challenge for doctors
Keywords:
melanoma, melanonichia, lentiginous acral melanoma, amputationAbstract
Subungual melanoma is a subgroup of lentiginous acral melanoma. It is often diagnosed in an advanced stage by a shortage of symptoms, so timely evaluation and treatment improve prognosis. This is the case of a 44-year-old patient who goes to orthopedics with melanonichia 3 months of evolution. He had been treated for a bruise secondary to direct trauma to the distal phalanx of the first left foot ailre in primary health care. It was followed by external orthopedic consultation and by not following an adequate evolution was evaluated by the provincial commission of peripheral tumors. He was given a punch biopsy resulting in a subungual melanoma. The amputation of the first artejo and proximal first metatarsal was carried out, once verified the non-existence of metastatic lesions, with excellent aesthetic and functional result, without showing relapse in its follow-up to two years.Downloads
References
2).Pinheiro P. Melanoma-cáncer de piel. MD. Saúde. 2018 [citado 28 Oct 2018]. Disponible en: https://www.mdsaude.com/es/2015/12/melanoma.html
3).Nova John Alexander, Sánchez-Vanegas Guillermo, Gamboa Mauricio, Gil-Quiñones Sebastian Ramiro. Melanoma risk factors in a Latin American population, An. Bras. Dermatology. [Internet]. 2020 Aug [cited 2020 Oct 10]; 95(4): 531-533. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962020000400023&lng=en
4).Swetter SM, Tsao H, Bichakjian CK, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatoly. 2019; 80: 208-50. PMID: 30392755, DOI: 10.1016/j.jaad.2018.08.055
5).Robles Méndez JC, Guerrero-González GA, Domínguez-Cherit JG, Vázquez-Martínez OT, Ocampo Candiani J. Melanoma ungueal. Dermatol Rev Mex [Internet]. 2016 mar [citado 2020 Oct 10]; 60(2):163-6. Disponible en: https://www.medigraphic.com/pdfs/derrevmex/rmd-2016/rmd162i.pdf
6).Purim Kátia Sheylla Malta, Bonetti João Pedro Ceccon, Silva Juliane Yumi Furuta, Marques Laura Boletta, Pinto Maria Catarino Simões, Ribeiro Leandro Carvalho. Características do melanoma em idosos. Rev. Col. Bras. Cir. [Internet]. 2020 [cited 2020 Oct 10]; 47: e2020-2441. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S010069912020000100175&lng=en
7).Kraft Rovere R, Pires ME. Melanoma patterns of distant relapse: a study of 108 cases from a South Brazilian center. A Bras Dermatoly [Internet]. 2016 [citado 2020 Oct 10]; 91(1): 40-3. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782645/pdf/abd-91-01-0040.pdf
8).Swetter SM, Tsao H, Bichakjian CK, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2019; 80: 208-50. PMID: 30392755, DOI: 10.1016/j.jaad.2018.08.055
9).Castro JI, Valerio J, Herrera S. Melanoma subungueal de la mano: reporte de un caso. Rev. Argent. Dermatol. [Internet]. 2016 Jun [citado 2020 Oct 10]; 97(2): 47-56. Disponible en:
http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S1851-300X2016000200008&lng=es
10).Méndez-Mathey VE. Metástasis cerebral de melanoma lentiginoso acral. Rev. Fac. Med. 2019; 67(1):165-8. Spanish. Doi: http://dx.doi.org/10.15446/revfacmed.v67n1.62826.
11).Tas F, Erturk K. Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors. Melanoma Res. 2017 Apr;27(2):134-139. PMID: 28099368 DOI: 10.1097/CMR.0000000000000332
12).Pramio DT, Kashiwabara AY, Pennacchi PC, Rivas MP, Maria-Engler SS, Antônio HJ, et al. Epigenetic signature of differentially methylated genes in cutaneous melanoma. Applied Cancer Research. 2017; 37: 34. DOI: https://doi.org/10.1186/s41241-017-0041-9
13). Linertová R, Valcárcel-Nazco C, Lacalle-Remigio JR. Tratamiento quirúrgico de lesiones melanocíticas benignas para la prevención del melanoma. Medicina Clínica (English Edition). 2016; 147(4): 162-70.
ID MEDES: 113633 DOI: 10.1016/j.medcli.2016.02.016
Published
How to Cite
Issue
Section
License
All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.
It allows:
- Copy and redistribute published material in any medium or format.
- Adapt the content.
This will be done under the following terms:
- Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.
- Non-commercial use.
- Recognize the journal where it is published.
The copyrights of each article are maintained, without restrictions.